null

MonoMethyl-Histone H3-K36 Antibody (CAB2364)

SKU:
CAB2364
Product Type:
Antibody
Applications:
WB
IHC
IF
IP
ChIP
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-MonoMethyl-Histone H3-K36 Antibody CAB2364
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-MonoMethyl-Histone H3-K36 Antibody CAB2364
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-MonoMethyl-Histone H3-K36 Antibody CAB2364
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-MonoMethyl-Histone H3-K36 Antibody CAB2364
  • Epigenetics and Nuclear Signaling Antibodies 3 Anti-MonoMethyl-Histone H3-K36 Antibody CAB2364
$167 - $503
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Anti-MonoMethyl-Histone H3-K36 Antibody (CAB2364)

The Monomethyl Histone H3 (K36) Polyclonal Antibody (CAB2364) is a valuable tool for researchers studying epigenetic modifications and their impact on gene expression. Histone H3 lysine 36 monomethylation is a crucial modification involved in transcriptional activation and elongation processes. This antibody, raised in rabbits, specifically targets the monomethylated form of histone H3 at lysine 36 and is highly reactive in human samples.Validated for use in Western blot applications, the Monomethyl Histone H3 (K36) Polyclonal Antibody (CAB2364) allows for the detection and analysis of this epigenetic mark in various cell types. Its specificity and sensitivity make it an ideal tool for research in the fields of epigenetics, chromatin biology, and gene regulation.

Understanding the role of histone H3 lysine 36 monomethylation is essential for unraveling the complex network of epigenetic mechanisms that control gene expression. This antibody provides researchers with a reliable means to investigate the functions of this modification in normal cellular processes and diseases such as cancer, developmental disorders, and neurodegenerative conditions. Unlocking the secrets of histone H3 lysine 36 monomethylation could lead to new therapeutic strategies targeting epigenetic pathways for the treatment of various diseases.